Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis
ItalyStudy Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
ItalyStudy of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma
ItalyStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
ItalyStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
ItalyStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
ItalyStudy on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia
ItalyItalyStudy on Treprostinil Palmitil Inhalation Powder for Patients with Pulmonary Arterial Hypertension
ItalyStudy of venglustat tablets to reduce neuropathic and abdominal pain in patients aged 16 and older with Fabry disease who are untreated or haven't received treatment for 6 months
ItalyStudy on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis
ItalyStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
